Evaluation of the " Tele-follow-up " for the Follow-up of Implantable Defibrillators
EVATEL
4 other identifiers
interventional
1,501
1 country
30
Brief Summary
The implantable cardioverter defibrillator (ICD) has been shown to be effective in preventing mortality in patients with ventricular tachyarrhythmia. However, the expanding indications of this therapy will have an impact on the follow-up policy. Currently, regular follow-up visits are scheduled every 3 months. In this context, the recently-introduced "remote monitoring" devices constitute a promising new technique, allowing to transmit information about the status of the device and ICD therapies, without direct contact between patients and physicians. This monitoring by "tele-follow-up" might reduce the cost of care by avoiding useless visits to the implantation centre. The aim of our study is to assess the cost-benefit ratio of "tele-follow-up" assisted care as compared with the conventional ICD follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2008
Typical duration for not_applicable
30 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2008
CompletedStudy Start
First participant enrolled
January 14, 2008
CompletedFirst Posted
Study publicly available on registry
January 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2011
CompletedMay 11, 2023
May 1, 2023
3.1 years
January 9, 2008
May 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of major cardiovascular events: all cause death, hospitalisation for a cardiovascular event, unsuccessful ICD therapies, and inappropriate ICD therapies.
1 year
Secondary Outcomes (11)
Time to onset of the first major cardiovascular event (censored criterion)
1 year
Death rate
1 year
Hospitalisation rate for a cardiovascular event
1 year
Rate of unsuccessful or inappropriate ICD therapies
1 year
Mean costs of each follow-up strategy
1 year
- +6 more secondary outcomes
Study Arms (2)
1
EXPERIMENTALTele- follow-up: remote transmission to the implantation centre every 3 months
2
ACTIVE COMPARATORConventional follow-up: visits at the implantation centre every 3 months
Interventions
Eligibility Criteria
You may qualify if:
- Adults over 18,
- First implantation of an implantable cardioverter defibrillator device (CRT-D devices being excluded), single or dual-chamber in primary or secondary prevention,
- ICD with data-transmission features,
- GSM mobile phone network at patient home compatible with remote transmission,
- Patient able to use correctly the transmission system,
- Patients having given a written informed consent.
You may not qualify if:
- Class IV of NYHA,
- Concomitant pathology leading to a life expectancy inferior to the protocol duration,
- Concomitant participation to another protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rennes University Hospitallead
- Ministry of Health, Francecollaborator
Study Sites (30)
Service de Cardiologie - Centre Hospitalier du Pays d'Aix
Aix-en-Provence, 13100, France
Service de Cardiologie - CHU d'Angers
Angers, 49033, France
Service de Cardiologie - CHU Jean Minjoz
Besançon, 25000, France
Service de Cardiologie -Hôpital de la Cavale Blanche
Brest, 29609, France
Service de Cardiologie - Groupement Hospitalier Est de Lyon
Bron, 69677, France
Service de Cardiologie - Hôpital de la Côte de Nacre
Caen, 14000, France
Service de Cardiologie - CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
Service de Cardiologie - Hôpital Henri Mondor
Créteil, France
Centre de Cardiologie - CHU de Dijon
Dijon, 21000, France
Service de cardiologie et Urgences cardiologiques - Hôpital Michallon
Grenoble, 38043, France
Cardiologie A - CHRU de Lille
Lille, 59037, France
Service de Cardiologie - CHU de Limoges
Limoges, 87042, France
Service de Cardiologie - CHU Timone Adultes
Marseille, 13385, France
Département de Cardiologie - CHU de Montpellier
Montpellier, 34295, France
Service de Cardiologie - Institut du Thorax - Hôpital Laennec
Nantes, 44093, France
Service de Cardiologie - Hôpital Pasteur
Nice, 06002, France
Service de Cardiologie - CHU de Nîmes
Nîmes, 30029, France
Service de Cardiologie - Hôpital Européen Georges Pompidou
Paris, 75015, France
Service de Cardiologie - Hôpital Lariboisière
Paris, 75475, France
Institut de Cardiologie - Hôpital de la Pitité Salpétrière
Paris, 75651, France
Hôpital Cardiologique du Haut Lévêque - CHU de Bordeaux
Pessac, 33604, France
Service médico-chirurgical de Cardiologie - CHU de Poitiers
Poitiers, 86021, France
Département de Cardiologie - CHU de Reims
Reims, 51092, France
Département de Cardiologie et Maladies Vasculaires - Hôpital de Pontchaillou
Rennes, 35033, France
Service de Cardiologie - Hôpital Charles Nicolle
Rouen, 76031, France
Service de Cardiologie - CHU de Saint Etienne
Saint-Etienne, 42000, France
Service de Cardiologie - Hôpital de Hautepierre
Strasbourg, 67098, France
Service de Chirurgie Cardiovasculaire - Hôpital Rangueil
Toulouse, 31059, France
Service de Cardiologie B - Hôpital Trousseau
Tours, 37044, France
Département de Cardiologie - CHU de Nancy-Brabois
Vandœuvre-lès-Nancy, 54511, France
Study Officials
- STUDY DIRECTOR
Philippe MABO, MD, PhD
Rennes University Hospital
- STUDY CHAIR
Eric BELLISSANT, MD, PhD
Rennes University Hospital
- STUDY CHAIR
Isabelle DURAND-ZALESKI, MD, PhD
Creteil University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2008
First Posted
January 18, 2008
Study Start
January 14, 2008
Primary Completion
March 7, 2011
Study Completion
March 7, 2011
Last Updated
May 11, 2023
Record last verified: 2023-05